BPC-157 IS ONE of the hottest peptides on the (gray) market
Even the ELIXA trial showed decreasing albuminuria [19]
Conversely, 10 proteins were downregulated, including STAM Binding Protein (STAMBP), Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2), Axin Protein 1 (AXIN1), Delta/Notch EGF Repeat-Containing (DNER), Ephrin Type-B Receptor 6 (EPHB6), Neutral Endopeptidase (NEP), Fibroblast Growth Factor 5 (FGF-5), Neuronal Cell Adhesion Molecule (Nr-CAM), Spondin 1 (SPOCK1) and S SH2 Domain Containing 1 A (SH2D1A)
BPC-157 dominates for specific injury sites, gut issues, and localised damage
Information about case ascertainment was not provided for eight studies [48, 49, 54, 59, 74, 78, 81, 84]